Showing results (61-70 of 370) with videos related to
Sort By:
Pageof 37
Microbes and Infection|December 31, 2017
Cellular interactions of covR/S mutant group A StreptococciEmma L Langshaw, Manisha Pandey, Michael F GoodCurrent Infectious Disease Reports|June 26, 2012
Vaccination against rheumatic heart disease: a review of current research strategies and challengesManisha Pandey, Michael R Batzloff, Michael F GoodEuropean Journal of Medicinal Chemistry|October 28, 2018
Nature-inspired development of unnatural meroterpenoids as the non-toxic anti-colon cancer agentsMd Ashraful Haque, Bethsebie L Sailo, Ganesan Padmavathi, et al.Trends in Parasitology|April 17, 2020
Malaria Parasite Clearance: What Are We Really Measuring?David S Khoury, Sophie G Zaloumis, Matthew J Grigg, et al.Journal of Medical Internet Research|November 22, 2018
Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation StudyChee Kin Lam, Kara McGinnis Pilote, Ashraful Haque, et al.Infection and Immunity|March 24, 2005
Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malariaSalenna R Elliott, Rachel D Kuns, Michael F GoodTrends in Parasitology|November 2, 2013
Escaping the immune system: How the malaria parasite makes vaccine development a challengeDanielle I Stanisic, Alyssa E Barry, Michael F GoodMicrobes and Infection|December 31, 2017
Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine developmentLeanne M Low, Danielle I Stanisic, Michael F GoodInfection and Immunity|April 26, 2017
Chemical Attenuation in the Development of a Whole-Organism Malaria VaccineAmber I Raja, Danielle I Stanisic, Michael F GoodThe Journal of Trauma and Acute Care Surgery|August 24, 2012
Initial evaluation of a nano-engineered hemostatic agent in a severe vascular and organ hemorrhage swine modelFrançoise Arnaud, Tomoaki Okada, Daniel Solomon, et al.Pageof 37